MCKESSON CORP (MCK) Stock News
NYSE:MCK - New York Stock Exchange, Inc. - US58155Q1031 - Common Stock - Currency: USD
MCK Latest News, Press Relases and Analysis
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Top S&P500 movers in Monday's pre-market session
Get insights into the top gainers and losers in the S&P500 index of Monday's pre-market session.
3 Reasons Growth Investors Will Love McKesson (MCK)
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Large-Cap Stocks for Long-Term Investors and 1 to Turn Down
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Target downgraded, Wayfair upgraded: Wall Street's top analyst calls
Target downgraded, Wayfair upgraded: Wall Street's top analyst calls
Insurance broker Hub valued at $29 billion in fresh investment round
(Reuters) -Hub International has raised nearly $1.6 billion in a funding round that valued the Hellman & Friedman-backed insurance broker at $29 billion and was led by T Rowe Price, Alpha Wave Global and Singapore's state investor Temasek. Such deals allow buyout firms to retain their portfolio companies longer while widening the investor base. Hub, acquired by H&F in a $4.4 billion deal in 2013, said on Monday it does not expect to use the proceeds to meet redemption requests for investors.
Here’s Why Baron Health Care Fund Reacquired McKesson Corporation (MCK) in Q1
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]
Why McKesson Stock Bumped Modestly Higher Today
The company posted double-digit-percentage improvements in its latest set of quarterly results. Storied healthcare supplies company McKesson (NYSE: MCK) was a slight outperformer on the stock exchange Friday, as investors considered its results for its fourth quarter of fiscal 2025. After market hours Thursday, McKesson divulged that it earned revenue of $90.8 billion for the period, a meaty 19% improvement over the same quarter the previous year.
Why McKesson Stock Bumped Modestly Higher Today
1 Artificial Intelligence (AI) Stock That Could Soar in the Second Half of 2025 and Beyond
Twilio stock has recovered impressively in the past month, and its rally seems here to stay. The company's focus on integrating AI tools into its cloud communications platform is paying off. Twilio's earnings growth rate is expected to pick up going forward, and its attractive valuation suggests that investors are getting a good deal right now.
Why Alarm.com Holdings Stock Was a Winner Today
The company took the wraps off its first-quarter results. Revenue and profitability both rose; they also topped analyst estimates. Alarm.com Holdings (NASDAQ: ALRM), a company specializing technology-fueled security products and services, unveiled its first-quarter financial results Friday morning, and investors found them the opposite of alarming.
MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off
McKesson's fourth-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
Ripple and SEC submit joint settlement
The SEC and Ripple Labs have filed a joint settlement agreement letter.
Here's What Key Metrics Tell Us About McKesson (MCK) Q4 Earnings
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
McKesson (NYSE:MCK) Misses Q1 Revenue Estimates
Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 18.9% year on year to $90.82 billion. Its non-GAAP profit of $10.12 per share was 3% above analysts’ consensus estimates.
McKesson (MCK) Tops Q4 Earnings Estimates
McKesson (MCK) delivered earnings and revenue surprises of 3.16% and 3.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: CGEN
Which S&P500 stocks are showing activity after the closing bell on Thursday?
Discover the top S&P500 movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Top S&P500 movers in Thursday's session
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.
Discover which S&P500 stocks are making waves on Thursday.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Jim Cramer on McKesson (MCK): “Defying Doubters as a Middleman Money Machine”
We recently published a list of Jim Cramer Reveals Trump’s Potential Secret Weapon In China Trade Talks & Discusses These 10 Stocks. In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other stocks that Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the […]
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet
The average brokerage recommendation (ABR) for McKesson (MCK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings?
McKesson's fourth-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.